[8-K] Innovative Solutions & Support Reports Material Event
Innovative Solutions & Support (ISSC) signed a new five-year Credit Agreement with JPMorgan Chase on 18 Jul 2025 providing up to $100 million in committed financing.
- Revolver: $30 m; availability for working capital & general corporate use.
- Initial Term Loan: $25 m drawn immediately; quarterly amortization of $0.625 m begins 30 Sep 2025.
- Delayed-Draw Term Loan: $45 m available solely for permitted acquisitions; 2.5 % quarterly amortization starts after 18 Jan 2026.
The facility replaces a $35 m PNC revolver, refinancing that debt and increasing total liquidity by $65 m. All loans mature five years from first advance and are secured by substantially all domestic assets, including the Exton, PA headquarters. Borrowings bear interest at either (i) Alternate Base Rate +0.75–1.75 % or (ii) Term SOFR +1.75–2.75 %, depending on total net leverage; default rate is +200 bp. Covenants restrict additional debt, liens, investments, dispositions and dividends; cross-default threshold is $2.5 m. ISSC may request a further $25 m in incremental commitments, subject to lender consent.
The arrangement significantly extends borrowing capacity and funds potential M&A, but increases secured leverage and exposes the company to floating-rate costs.
- Credit capacity more than doubled: replaces $35 m line with $100 m multi-tranche facility.
- Dedicated acquisition financing: $45 m delayed-draw term loan earmarked for M&A growth.
- Option for additional $25 m incremental commitments provides further flexibility.
- Higher secured leverage potential could pressure future cash flows and covenants.
- Floating-rate exposure (SOFR-linked) increases earnings sensitivity to rate hikes.
Insights
TL;DR: New $100 m facility boosts liquidity and M&A capacity; leverage and rate risk rise.
The JPMorgan-led agreement nearly triples ISSC’s available credit, immediately refinancing the $35 m PNC line while leaving ~$70 m undrawn. Management gains flexibility to pursue acquisitions through the $45 m delayed-draw tranche, signalling a growth-by-M&A strategy. Covenants appear standard and leverage-based pricing (SOFR +1.75–2.75 %) is reasonable for an aerospace avionics supplier of ISSC’s size. While the deal strengthens the balance-sheet’s liquidity profile, investors should monitor incremental debt use, interest-expense impact in a rising-rate environment, and the company’s ability to keep net leverage within stepped pricing tiers.
TL;DR: Secured, covenant-heavy structure protects lenders; leverage headroom tight.
The facility is fully secured by all domestic assets and the Exton real estate, offering solid collateral. Quarterly amortization on term loans and a 5-year bullet on the revolver reduce refinancing risk. However, the cross-default trigger is low ($2.5 m), and restrictive covenants could limit financial flexibility if earnings soften. Variable-rate exposure leaves ISSC vulnerable to higher SOFR prints; a 100 bp rise could add ~$1 m annual interest if fully drawn. Overall risk to lenders remains moderate; to equity holders, incremental leverage is manageable but warrants scrutiny.